Catalyst Biosciences Receives Rare Pediatric Disease : vimar

SOUTH SAN FRANCISCO, Calif., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced the U.S. Food and Drug...

Related Keywords

Nassim Usman , Exchange Commission , Company Annual Report On Form , Drug Administration , Catalyst Biosciences Inc , Nasdaq , Rare Pediatric Disease Designation , Catalyst Biosciences , Protease Medicines , Annual Report , Quarterly Report , Nasdaq Cbio , Nc ,